Global Ankylosing Spondylitis Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1913548
- Published On: Aug, 2020
- Category : Consumer and general services
- Pages : 121
-
The Ankylosing Spondylitis market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Ankylosing Spondylitis industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Ankylosing Spondylitis market can be split based on product types, major applications, and important countries as follows:
Key players in the global Ankylosing Spondylitis market covered in Chapter 12:
Abbvie
Merck & Co.
UCB
Merck Sharp & Dohme
Boehringer Ingelheim
Janssen Pharmaceuticals
F. Hoffmann-La Roche
Regeneron Pharmaceuticals
Sanofi
Celgene
Otsuka Pharmaceutical
Shanghai Pharmaceuticals
Eisai
Bristol-Myers Squibb
Novartis
Pfizer
Amgen
Celltrion
In Chapter 4 and 14.1, on the basis of types, the Ankylosing Spondylitis market from 2015 to 2025 is primarily split into:
TNF Inhibitors
COX Inhibitors
Others
In Chapter 5 and 14.2, on the basis of applications, the Ankylosing Spondylitis market from 2015 to 2025 covers:
Oral
Parenteral
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Ankylosing Spondylitis market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Ankylosing Spondylitis Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Ankylosing Spondylitis
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Ankylosing Spondylitis industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Ankylosing Spondylitis Market Size, 2015 – 2020
2.1.2 Global Ankylosing Spondylitis Market Size by Type, 2015 – 2020
2.1.3 Global Ankylosing Spondylitis Market Size by Application, 2015 – 2020
2.1.4 Global Ankylosing Spondylitis Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Ankylosing Spondylitis Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Ankylosing Spondylitis Analysis
3.2 Major Players of Ankylosing Spondylitis
3.3 Ankylosing Spondylitis Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Ankylosing Spondylitis
3.3.3 Labor Cost of Ankylosing Spondylitis3.4 Market Distributors of Ankylosing Spondylitis
3.5 Major Downstream Buyers of Ankylosing Spondylitis Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Ankylosing Spondylitis Market, by Type4.1 Global Ankylosing Spondylitis Value and Market Share by Type (2015-2020)
4.2 Global Ankylosing Spondylitis Production and Market Share by Type (2015-2020)
4.3 Global Ankylosing Spondylitis Value and Growth Rate by Type (2015-2020)
4.3.1 Global Ankylosing Spondylitis Value and Growth Rate of TNF Inhibitors
4.3.2 Global Ankylosing Spondylitis Value and Growth Rate of COX Inhibitors
4.3.3 Global Ankylosing Spondylitis Value and Growth Rate of Others4.4 Global Ankylosing Spondylitis Price Analysis by Type (2015-2020)
5 Ankylosing Spondylitis Market, by Application5.1 Downstream Market Overview
5.2 Global Ankylosing Spondylitis Consumption and Market Share by Application (2015-2020)
5.3 Global Ankylosing Spondylitis Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Ankylosing Spondylitis Consumption and Growth Rate of Oral (2015-2020)
5.3.2 Global Ankylosing Spondylitis Consumption and Growth Rate of Parenteral (2015-2020)
6 Global Ankylosing Spondylitis Market Analysis by Regions6.1 Global Ankylosing Spondylitis Sales, Revenue and Market Share by Regions
6.1.1 Global Ankylosing Spondylitis Sales by Regions (2015-2020)
6.1.2 Global Ankylosing Spondylitis Revenue by Regions (2015-2020)6.2 North America Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
6.3 Europe Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
6.6 South America Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
7 North America Ankylosing Spondylitis Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Ankylosing Spondylitis Sales, Revenue and Market Share by Countries
7.2.1 North America Ankylosing Spondylitis Sales by Countries (2015-2020)
7.2.2 North America Ankylosing Spondylitis Revenue by Countries (2015-2020)7.3 United States Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
7.4 Canada Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
7.5 Mexico Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
8 Europe Ankylosing Spondylitis Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Ankylosing Spondylitis Sales, Revenue and Market Share by Countries
8.2.1 Europe Ankylosing Spondylitis Sales by Countries (2015-2020)
8.2.2 Europe Ankylosing Spondylitis Revenue by Countries (2015-2020)8.3 Germany Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
8.4 UK Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
8.5 France Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
8.6 Italy Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
8.7 Spain Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
8.8 Russia Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
9 Asia Pacific Ankylosing Spondylitis Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Ankylosing Spondylitis Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Ankylosing Spondylitis Sales by Countries (2015-2020)
9.2.2 Asia Pacific Ankylosing Spondylitis Revenue by Countries (2015-2020)9.3 China Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
9.4 Japan Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
9.5 South Korea Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
9.6 India Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
9.8 Australia Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
10 Middle East and Africa Ankylosing Spondylitis Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Ankylosing Spondylitis Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Ankylosing Spondylitis Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Ankylosing Spondylitis Revenue by Countries (2015-2020)10.3 Saudi Arabia Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
10.4 UAE Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
10.5 Egypt Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
10.6 Nigeria Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
10.7 South Africa Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
11 South America Ankylosing Spondylitis Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Ankylosing Spondylitis Sales, Revenue and Market Share by Countries
11.2.1 South America Ankylosing Spondylitis Sales by Countries (2015-2020)
11.2.2 South America Ankylosing Spondylitis Revenue by Countries (2015-2020)11.3 Brazil Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
11.4 Argentina Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
11.5 Columbia Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
11.6 Chile Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Abbvie
12.1.1 Abbvie Basic Information
12.1.2 Ankylosing Spondylitis Product Introduction
12.1.3 Abbvie Production, Value, Price, Gross Margin 2015-202012.2 Merck & Co.
12.2.1 Merck & Co. Basic Information
12.2.2 Ankylosing Spondylitis Product Introduction
12.2.3 Merck & Co. Production, Value, Price, Gross Margin 2015-202012.3 UCB
12.3.1 UCB Basic Information
12.3.2 Ankylosing Spondylitis Product Introduction
12.3.3 UCB Production, Value, Price, Gross Margin 2015-202012.4 Merck Sharp & Dohme
12.4.1 Merck Sharp & Dohme Basic Information
12.4.2 Ankylosing Spondylitis Product Introduction
12.4.3 Merck Sharp & Dohme Production, Value, Price, Gross Margin 2015-202012.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Basic Information
12.5.2 Ankylosing Spondylitis Product Introduction
12.5.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-202012.6 Janssen Pharmaceuticals
12.6.1 Janssen Pharmaceuticals Basic Information
12.6.2 Ankylosing Spondylitis Product Introduction
12.6.3 Janssen Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.7 F. Hoffmann-La Roche
12.7.1 F. Hoffmann-La Roche Basic Information
12.7.2 Ankylosing Spondylitis Product Introduction
12.7.3 F. Hoffmann-La Roche Production, Value, Price, Gross Margin 2015-2020
12.8 Regeneron Pharmaceuticals
12.8.1 Regeneron Pharmaceuticals Basic Information
12.8.2 Ankylosing Spondylitis Product Introduction
12.8.3 Regeneron Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.9 Sanofi
12.9.1 Sanofi Basic Information
12.9.2 Ankylosing Spondylitis Product Introduction
12.9.3 Sanofi Production, Value, Price, Gross Margin 2015-202012.10 Celgene
12.10.1 Celgene Basic Information
12.10.2 Ankylosing Spondylitis Product Introduction
12.10.3 Celgene Production, Value, Price, Gross Margin 2015-2020
12.11 Otsuka Pharmaceutical
12.11.1 Otsuka Pharmaceutical Basic Information
12.11.2 Ankylosing Spondylitis Product Introduction
12.11.3 Otsuka Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.12 Shanghai Pharmaceuticals
12.12.1 Shanghai Pharmaceuticals Basic Information
12.12.2 Ankylosing Spondylitis Product Introduction
12.12.3 Shanghai Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.13 Eisai
12.13.1 Eisai Basic Information
12.13.2 Ankylosing Spondylitis Product Introduction
12.13.3 Eisai Production, Value, Price, Gross Margin 2015-2020
12.14 Bristol-Myers Squibb
12.14.1 Bristol-Myers Squibb Basic Information
12.14.2 Ankylosing Spondylitis Product Introduction
12.14.3 Bristol-Myers Squibb Production, Value, Price, Gross Margin 2015-2020
12.15 Novartis
12.15.1 Novartis Basic Information
12.15.2 Ankylosing Spondylitis Product Introduction
12.15.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.16 Pfizer
12.16.1 Pfizer Basic Information
12.16.2 Ankylosing Spondylitis Product Introduction
12.16.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.17 Amgen
12.17.1 Amgen Basic Information
12.17.2 Ankylosing Spondylitis Product Introduction
12.17.3 Amgen Production, Value, Price, Gross Margin 2015-2020
12.18 Celltrion
12.18.1 Celltrion Basic Information
12.18.2 Ankylosing Spondylitis Product Introduction
12.18.3 Celltrion Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Ankylosing Spondylitis Market Forecast14.1 Global Ankylosing Spondylitis Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 TNF Inhibitors Market Value and Volume Forecast (2020-2025)
14.1.2 COX Inhibitors Market Value and Volume Forecast (2020-2025)
14.1.3 Others Market Value and Volume Forecast (2020-2025)14.2 Global Ankylosing Spondylitis Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Oral Market Value and Volume Forecast (2020-2025)
14.2.2 Parenteral Market Value and Volume Forecast (2020-2025)14.3 Ankylosing Spondylitis Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Ankylosing Spondylitis
Table Product Specification of Ankylosing Spondylitis
Table Ankylosing Spondylitis Key Market Segments
Table Key Players Ankylosing Spondylitis Covered
Figure Global Ankylosing Spondylitis Market Size, 2015 – 2025
Table Different Types of Ankylosing Spondylitis
Figure Global Ankylosing Spondylitis Value ($) Segment by Type from 2015-2020
Figure Global Ankylosing Spondylitis Market Share by Types in 2019
Table Different Applications of Ankylosing Spondylitis
Figure Global Ankylosing Spondylitis Value ($) Segment by Applications from 2015-2020
Figure Global Ankylosing Spondylitis Market Share by Applications in 2019
Figure Global Ankylosing Spondylitis Market Share by Regions in 2019
Figure North America Ankylosing Spondylitis Production Value ($) and Growth Rate (2015-2020)
Figure Europe Ankylosing Spondylitis Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Ankylosing Spondylitis Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Ankylosing Spondylitis Production Value ($) and Growth Rate (2015-2020)
Figure South America Ankylosing Spondylitis Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Ankylosing Spondylitis
Table Upstream Raw Material Suppliers of Ankylosing Spondylitis with Contact Information
Table Major Players Headquarters, and Service Area of Ankylosing Spondylitis
Figure Major Players Production Value Market Share of Ankylosing Spondylitis in 2019
Table Major Players Ankylosing Spondylitis Product Types in 2019
Figure Production Process of Ankylosing Spondylitis
Figure Manufacturing Cost Structure of Ankylosing Spondylitis
Figure Channel Status of Ankylosing Spondylitis
Table Major Distributors of Ankylosing Spondylitis with Contact Information
Table Major Downstream Buyers of Ankylosing Spondylitis with Contact Information
Table Global Ankylosing Spondylitis Value ($) by Type (2015-2020)
Table Global Ankylosing Spondylitis Value Share by Type (2015-2020)
Figure Global Ankylosing Spondylitis Value Share by Type (2015-2020)
Table Global Ankylosing Spondylitis Production by Type (2015-2020)
Table Global Ankylosing Spondylitis Production Share by Type (2015-2020)
Figure Global Ankylosing Spondylitis Production Share by Type (2015-2020)
Figure Global Ankylosing Spondylitis Value ($) and Growth Rate of TNF Inhibitors (2015-2020)
Figure Global Ankylosing Spondylitis Value ($) and Growth Rate of COX Inhibitors (2015-2020)
Figure Global Ankylosing Spondylitis Value ($) and Growth Rate of Others (2015-2020)
Figure Global Ankylosing Spondylitis Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Ankylosing Spondylitis Consumption by Application (2015-2020)
Table Global Ankylosing Spondylitis Consumption Market Share by Application (2015-2020)
Figure Global Ankylosing Spondylitis Consumption Market Share by Application (2015-2020)
Figure Global Ankylosing Spondylitis Consumption and Growth Rate of Oral (2015-2020)
Figure Global Ankylosing Spondylitis Consumption and Growth Rate of Parenteral (2015-2020)
Figure Global Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Global Ankylosing Spondylitis Revenue (M USD) and Growth (2015-2020)
Table Global Ankylosing Spondylitis Sales by Regions (2015-2020)
Table Global Ankylosing Spondylitis Sales Market Share by Regions (2015-2020)
Table Global Ankylosing Spondylitis Revenue (M USD) by Regions (2015-2020)
Table Global Ankylosing Spondylitis Revenue Market Share by Regions (2015-2020)
Table Global Ankylosing Spondylitis Revenue Market Share by Regions in 2015
Table Global Ankylosing Spondylitis Revenue Market Share by Regions in 2019
Figure North America Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Europe Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure South America Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Ankylosing Spondylitis Revenue (M USD) and Growth (2015-2020)
Table North America Ankylosing Spondylitis Sales by Countries (2015-2020)
Table North America Ankylosing Spondylitis Sales Market Share by Countries (2015-2020)
Table North America Ankylosing Spondylitis Revenue (M USD) by Countries (2015-2020)
Table North America Ankylosing Spondylitis Revenue Market Share by Countries (2015-2020)
Figure United States Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Canada Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Mexico Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Ankylosing Spondylitis Revenue (M USD) and Growth (2015-2020)
Table Europe Ankylosing Spondylitis Sales by Countries (2015-2020)
Table Europe Ankylosing Spondylitis Sales Market Share by Countries (2015-2020)
Table Europe Ankylosing Spondylitis Revenue (M USD) by Countries (2015-2020)
Table Europe Ankylosing Spondylitis Revenue Market Share by Countries (2015-2020)
Figure Germany Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure UK Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure France Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Italy Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Spain Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Russia Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Ankylosing Spondylitis Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Ankylosing Spondylitis Sales by Countries (2015-2020)
Table Asia Pacific Ankylosing Spondylitis Sales Market Share by Countries (2015-2020)
Table Asia Pacific Ankylosing Spondylitis Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Ankylosing Spondylitis Revenue Market Share by Countries (2015-2020)
Figure China Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Japan Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure South Korea Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure India Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Southeast Asia Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Australia Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Middle East Ankylosing Spondylitis Revenue (M USD) and Growth (2015-2020)
Table Middle East Ankylosing Spondylitis Sales by Countries (2015-2020)
Table Middle East and Africa Ankylosing Spondylitis Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Ankylosing Spondylitis Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Ankylosing Spondylitis Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure UAE Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Egypt Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Nigeria Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure South Africa Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure South America Ankylosing Spondylitis Revenue (M USD) and Growth (2015-2020)
Table South America Ankylosing Spondylitis Sales by Countries (2015-2020)
Table South America Ankylosing Spondylitis Sales Market Share by Countries (2015-2020)
Table South America Ankylosing Spondylitis Revenue (M USD) by Countries (2015-2020)
Table South America Ankylosing Spondylitis Revenue Market Share by Countries (2015-2020)
Figure Brazil Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Argentina Ankylosing Spondylitis Sales and Growth Rate (2015-2020)
Figure Columbia Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Chile Ankylosing Spondylitis Sales and Growth (2015-2020)
Figure Top 3 Market Share of Ankylosing Spondylitis Companies in 2019
Figure Top 6 Market Share of Ankylosing Spondylitis Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Abbvie Profile
Table Abbvie Product Introduction
Figure Abbvie Production and Growth Rate
Figure Abbvie Value ($) Market Share 2015-2020
Table Merck & Co. Profile
Table Merck & Co. Product Introduction
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2015-2020
Table UCB Profile
Table UCB Product Introduction
Figure UCB Production and Growth Rate
Figure UCB Value ($) Market Share 2015-2020
Table Merck Sharp & Dohme Profile
Table Merck Sharp & Dohme Product Introduction
Figure Merck Sharp & Dohme Production and Growth Rate
Figure Merck Sharp & Dohme Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Janssen Pharmaceuticals Profile
Table Janssen Pharmaceuticals Product Introduction
Figure Janssen Pharmaceuticals Production and Growth Rate
Figure Janssen Pharmaceuticals Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Product Introduction
Figure F. Hoffmann-La Roche Production and Growth Rate
Figure F. Hoffmann-La Roche Value ($) Market Share 2015-2020
Table Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Product Introduction
Figure Regeneron Pharmaceuticals Production and Growth Rate
Figure Regeneron Pharmaceuticals Value ($) Market Share 2015-2020
Table Sanofi Profile
Table Sanofi Product Introduction
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Table Celgene Profile
Table Celgene Product Introduction
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2015-2020
Table Otsuka Pharmaceutical Profile
Table Otsuka Pharmaceutical Product Introduction
Figure Otsuka Pharmaceutical Production and Growth Rate
Figure Otsuka Pharmaceutical Value ($) Market Share 2015-2020
Table Shanghai Pharmaceuticals Profile
Table Shanghai Pharmaceuticals Product Introduction
Figure Shanghai Pharmaceuticals Production and Growth Rate
Figure Shanghai Pharmaceuticals Value ($) Market Share 2015-2020
Table Eisai Profile
Table Eisai Product Introduction
Figure Eisai Production and Growth Rate
Figure Eisai Value ($) Market Share 2015-2020
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Product Introduction
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2015-2020
Table Novartis Profile
Table Novartis Product Introduction
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Amgen Profile
Table Amgen Product Introduction
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2015-2020
Table Celltrion Profile
Table Celltrion Product Introduction
Figure Celltrion Production and Growth Rate
Figure Celltrion Value ($) Market Share 2015-2020
Table Market Driving Factors of Ankylosing Spondylitis
Table Merger, Acquisition and New Investment
Table Global Ankylosing Spondylitis Market Value ($) Forecast, by Type
Table Global Ankylosing Spondylitis Market Volume Forecast, by Type
Figure Global Ankylosing Spondylitis Market Value ($) and Growth Rate Forecast of TNF Inhibitors (2020-2025)
Figure Global Ankylosing Spondylitis Market Volume ($) and Growth Rate Forecast of TNF Inhibitors (2020-2025)
Figure Global Ankylosing Spondylitis Market Value ($) and Growth Rate Forecast of COX Inhibitors (2020-2025)
Figure Global Ankylosing Spondylitis Market Volume ($) and Growth Rate Forecast of COX Inhibitors (2020-2025)
Figure Global Ankylosing Spondylitis Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Ankylosing Spondylitis Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oral (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oral (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Parenteral (2020-2025)
Figure Market Volume and Growth Rate Forecast of Parenteral (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Ankylosing Spondylitis Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
As manufacturers prepare to scale up, Global Ankylosing Spondylitis companies must be clear and transparent about the impact of such volatility on the balance sheet.
Depending upon the type of applications, the Global Ankylosing Spondylitis Market has been segmented into
The Global Ankylosing Spondylitis Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
Consumer behavior changes will reshape the entire decision-making process and companies in the Global Ankylosing Spondylitis Industry will need to adapt quickly.
During the forecast years, the Global Ankylosing Spondylitis Market can thrive with a robust CAGR.
